[DPHARMA] Extraordinary on 13-Aug-2021

Announcement Date
05-Jul-2021
Type
Extraordinary
Date & Time
13-Aug-2021 09:00
Depositor Date
06-Aug-2021
Venue
Online Meeting Platform using Remote Participation and Voting ("RPV") facilities via TIIH Online website at https://tiih.online
Description
DUOPHARMA BIOTECH BERHAD ("DUOPHARMA" OR THE "COMPANY") - NOTICE OF MEETING OF MEMBERS
Notice of MOM - Statement Accompanying Notice of MOM - Proxy Form and Administrative Guide.pdf
Outcome

The Board of Directors of Duopharma Biotech Berhad ("Duopharma Biotech" or the "Company”) wishes to announce that the ordinary resolution as set out in the Notice of the Meeting of Members ("MOM") dated 6 July 2021 has been passed by the shareholders of Duopharma Biotech at the MOM held today.

The voting in respect of the resolution wascarried out by way of poll and the result wasvalidated by Scrutineer Solutions Sdn. Bhd., the independent scrutineer appointed by Duopharma Biotech.

Please refer to the attachment for the resultof the poll as validated by the independent scrutineer.
This announcement is dated 13 August 2021.

Voting Results


1. ORDINARY RESOLUTION

Description
PROPOSED BONUS ISSUE OF 235,443,397 NEW ORDINARY SHARES IN DUOPHARMA BIOTECH BERHAD ("DUOPHARMA SHARES") ("BONUS SHARES") ON THE BASIS OF 1 BONUS SHARE FOR EVERY 3 EXISTING DUOPHARMA SHARES HELD ON AN ENTITLEMENT DATE TO BE DETERMINED AND ANNOUNCED LATER
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 568 49
No. of Shares 480,905,928 41,786
% of Voted Shares 99.9913 0.0087
Result Accepted

Remark
-
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment